NCT00590954 2020-10-19Clinical and Molecular-Metabolic Phase II Trial of Perifosine for Recurrent/Progressive Malignant GliomasMemorial Sloan Kettering Cancer CenterPhase 2 Completed32 enrolled 8 charts
NCT00389077 2018-03-07Trial of Two Schedules of Perifosine for Patients With Solid Tumors or LymphomasAEterna ZentarisPhase 2 Completed558 enrolled